clomipramine has been researched along with aripiprazole in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 11 (73.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abdallah, TA; Friedman, S; Guelfi, JD; Oumaya, M; Rouillon, F | 1 |
| Correa, H; da Rocha, FF | 1 |
| Bruno, A; Micò, U; Muscatello, MR; Pandolfo, G; Romeo, VM; Santoro, V; Scimeca, G; Settineri, S; Spina, E; Zoccali, RA | 1 |
| De Carolis, L; Milella, MS; Nencini, P; Schepisi, C | 1 |
| Catapano, F; Esposito, G; Fabrazzo, M; Maj, M; Monteleone, P; Perris, F | 1 |
| Ghezai, H; Goldacre, B; Hodsoll, J; Miles, S; Smallcombe, N; Veale, D | 1 |
| Cecconi, A; de Agustín, JA; Fernández-Jiménez, R; Fernández-Ortiz, A; Franco, E; Macaya, C; Palacios-Rubio, J; Sánchez-Enrique, C; Vilchez, JP | 1 |
| Amerio, A; Ghaemi, SN; Odone, A; Tonna, M | 1 |
| Beaulieu, AM; Osser, DN; Tabasky, E | 1 |
| Boavista, R; Chacon, P; Costa, DLDC; da Silva, RMF; de Barros, PMF; de Mathis, MA; de Oliveira, MVS; Diniz, JB; Echevarria, MAN; Ferrão, YA; Fontenelle, LF; Lopes, AC; Miguel, EC; Rosário, MCD; Shavitt, RG; Torres, AR; Vattimo, EFQ | 1 |
4 review(s) available for clomipramine and aripiprazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clomipramine; Dibenzothiazepines; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Humans; Obsessive-Compulsive Disorder; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2014 |
The psychopharmacology algorithm project at the Harvard South Shore Program: An algorithm for adults with obsessive-compulsive disorder.
Topics: Adult; Algorithms; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Clomipramine; Humans; Obsessive-Compulsive Disorder; Risperidone; Selective Serotonin Reuptake Inhibitors | 2019 |
Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Brazil; Clomipramine; Humans; Obsessive-Compulsive Disorder; Risperidone; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2023 |
2 trial(s) available for clomipramine and aripiprazole
| Article | Year |
|---|---|
Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Topics: Adult; Aged; Aripiprazole; Clomipramine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2011 |
Aripiprazole augmentation strategy in clomipramine-resistant depressive patients: an open preliminary study.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Clomipramine; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Piperazines; Prospective Studies; Quinolones; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Young Adult | 2012 |
9 other study(ies) available for clomipramine and aripiprazole
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Aripiprazole augmentation of clomipramine-refractory obsessive-compulsive disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Clomipramine; Drug Resistance; Drug Therapy, Combination; Humans; Male; Obsessive-Compulsive Disorder; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2007 |
Successful augmentation with aripiprazole in clomipramine-refractory obsessive-compulsive disorder.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Clomipramine; Drug Resistance; Drug Therapy, Combination; Humans; Male; Obsessive-Compulsive Disorder; Piperazines; Psychiatric Status Rating Scales; Quinolones | 2007 |
Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior.
Topics: Animals; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Clomipramine; Compulsive Behavior; Conditioning, Operant; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drinking Behavior; Haloperidol; Male; Piperazines; Quinolones; Quinpirole; Rats; Rats, Sprague-Dawley | 2011 |
Hyponatremia-induced stress cardiomyopathy due to psychogenic polydipsia.
Topics: Adult; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Aripiprazole; Chest Pain; Clomipramine; Coronary Angiography; Deep Brain Stimulation; Echocardiography; Electrocardiography; Humans; Hyponatremia; Male; Obsessive-Compulsive Disorder; Polydipsia, Psychogenic; Takotsubo Cardiomyopathy | 2016 |
The Osler's view: Treating comorbid bipolar disorder and obsessive-compulsive disorder.
Topics: Adult; Affect; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clomipramine; Depression, Postpartum; Diagnosis, Differential; Female; Fluvoxamine; Humans; Lithium Compounds; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales | 2017 |